In a study conducted on 270 patients with type 2 diabetes in Japan, it was reported that three months of sitagliptin treatment resulted in a decrease in PTX-3 levels compared to baseline values (1.88 (0.78)-1.65 (0.63) ng/ml; p=0.0038) [26]. The gene discussed is PTX3; the disease is type 2 diabetes mellitus.